Delf Schmidt

2.0k total citations · 2 hit papers
28 papers, 1.6k citations indexed

About

Delf Schmidt is a scholar working on Organic Chemistry, Molecular Biology and Surgery. According to data from OpenAlex, Delf Schmidt has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 9 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Delf Schmidt's work include Enzyme Production and Characterization (6 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Lipoproteins and Cardiovascular Health (4 papers). Delf Schmidt is often cited by papers focused on Enzyme Production and Characterization (6 papers), Carbohydrate Chemistry and Synthesis (6 papers) and Lipoproteins and Cardiovascular Health (4 papers). Delf Schmidt collaborates with scholars based in Germany, United States and Japan. Delf Schmidt's co-authors include Ernst Truscheit, Bodo Junge, W. Wingender, Lutz Müller, Werner Frommer, Wolf B. Frommer, Christian Wünsche, Jürgen Kurz, Hilmar Bischoff and Güntér Benz and has published in prestigious journals such as Nature, Angewandte Chemie International Edition and FEBS Letters.

In The Last Decade

Delf Schmidt

28 papers receiving 1.5k citations

Hit Papers

Chemistry and Biochemistry of Microbial α‐Glucosidase Inh... 1977 2026 1993 2009 1981 1977 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Delf Schmidt Germany 18 801 688 472 263 253 28 1.6k
Ernst Truscheit Germany 11 805 1.0× 648 0.9× 489 1.0× 251 1.0× 209 0.8× 17 1.5k
Bodo Junge Germany 9 602 0.8× 598 0.9× 423 0.9× 225 0.9× 231 0.9× 16 1.2k
Nikos G. Oikonomakos Greece 30 2.0k 2.5× 1.8k 2.6× 197 0.4× 240 0.9× 120 0.5× 81 2.8k
Sangku Lee South Korea 28 845 1.1× 758 1.1× 148 0.3× 64 0.2× 311 1.2× 101 2.0k
Gino Salituro United States 20 803 1.0× 392 0.6× 65 0.1× 282 1.1× 337 1.3× 46 1.6k
Pierangela Ciuffreda Italy 22 1.1k 1.3× 582 0.8× 87 0.2× 61 0.2× 269 1.1× 150 1.8k
J. HIRSHFIELD United States 6 1.4k 1.8× 871 1.3× 762 1.6× 53 0.2× 765 3.0× 13 2.6k
Nobuharu Shigematsu Japan 21 871 1.1× 647 0.9× 357 0.8× 40 0.2× 622 2.5× 50 1.7k
Michael Brands Germany 20 1.1k 1.4× 601 0.9× 112 0.2× 115 0.4× 353 1.4× 46 2.1k
Michel Koch France 28 1.3k 1.7× 1.3k 1.8× 128 0.3× 137 0.5× 414 1.6× 151 2.9k

Countries citing papers authored by Delf Schmidt

Since Specialization
Citations

This map shows the geographic impact of Delf Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delf Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delf Schmidt more than expected).

Fields of papers citing papers by Delf Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delf Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delf Schmidt. The network helps show where Delf Schmidt may publish in the future.

Co-authorship network of co-authors of Delf Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Delf Schmidt. A scholar is included among the top collaborators of Delf Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delf Schmidt. Delf Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Urbahns, Klaus, Michael Härter, Delf Schmidt, et al.. (2007). Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides. Bioorganic & Medicinal Chemistry Letters. 17(22). 6151–6154. 17 indexed citations
2.
Urbahns, Klaus, Michael Härter, Andrea Vaupel, et al.. (2003). Biphenyls as potent vitronectin receptor antagonists. Part 2: biphenylalanine ureas. Bioorganic & Medicinal Chemistry Letters. 13(6). 1071–1074. 17 indexed citations
3.
Urbahns, Klaus, Michael Härter, Delf Schmidt, et al.. (2002). Biphenyls as potent vitronectin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(2). 205–208. 19 indexed citations
4.
Bischoff, Hilmar, Rolf Angerbauer, D. Petzinna, et al.. (1998). Preclinical review of cerivastatin sodium—a step forward in HMG-CoA reductase inhibition. Atherosclerosis. 139. 7–13. 17 indexed citations
5.
Bischoff, Hilmar, Rolf Angerbauer, Erwin Bischoff, et al.. (1997). Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor. Atherosclerosis. 135(1). 119–130. 94 indexed citations
6.
Dinchuk, Joseph, et al.. (1995). Remodelling of lipoproteins in transgenic mice expressing human cholesteryl ester transfer protein. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1255(3). 301–310. 14 indexed citations
7.
Bischoff, Hilmar, H J Ahr, Delf Schmidt, & Jürgen Stoltefuß. (1994). Acarbose ‐ ein neues Wirkprinzip in der Diabetestherapie. Nachrichten aus Chemie Technik und Laboratorium. 42(11). 1119–1128. 20 indexed citations
8.
Stassen, F L, Delf Schmidt, Maryte Papadopoulos, et al.. (1988). Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.. Molecular Pharmacology. 33(2). 218–224. 20 indexed citations
9.
Stassen, F L, et al.. (1987). Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line.. Molecular Pharmacology. 31(3). 259–266. 24 indexed citations
10.
Stassen, F L, Delf Schmidt, P Nambi, et al.. (1987). A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.. PubMed. 31(3). 267–72. 11 indexed citations
11.
Gibbs, C. Parker, et al.. (1983). The Effectiveness of Sodium Citrate as an Antacid. Survey of Anesthesiology. 27(3). 139–139. 3 indexed citations
12.
Benz, Güntér, Jürgen Kurz, Christian Wünsche, et al.. (1982). Constitution of the Deferriform of the Albomycins δ1, δ2 and ε. Angewandte Chemie International Edition in English. 21(7). 527–528. 50 indexed citations
13.
Truscheit, Ernst, Wolf B. Frommer, Bodo Junge, et al.. (1981). ChemInform Abstract: CHEMISTRY AND BIOCHEMISTRY OF MICROBIAL α‐GLUCOSIDASE INHIBITORS. Chemischer Informationsdienst. 12(51). 1 indexed citations
14.
Truscheit, Ernst, Werner Frommer, Bodo Junge, et al.. (1981). Chemie und Biochemie mikrobieller α‐Glucosidasen‐Inhibitoren. Angewandte Chemie. 93(9). 738–755. 130 indexed citations
15.
Truscheit, Ernst, Werner Frommer, Bodo Junge, et al.. (1981). Chemistry and Biochemistry of Microbial α‐Glucosidase Inhibitors. Angewandte Chemie International Edition in English. 20(9). 744–761. 413 indexed citations breakdown →
16.
Schmidt, Delf, et al.. (1979). Glucosidase-Inhibitoren aus Bazillen. Die Naturwissenschaften. 66(11). 584–585. 128 indexed citations
17.
Schmidt, Delf, et al.. (1977). ?-Glucosidase inhibitors. Die Naturwissenschaften. 64(10). 535–536. 402 indexed citations breakdown →
18.
Hoffmann, Michael K., Delf Schmidt, & Herbert F. Oettgen. (1973). Production of Antibody to Sheep Red Blood Cells by Human Tonsil Cells in vitro. Nature. 243(5407). 408–410. 38 indexed citations
19.
Kerp, L., et al.. (1970). Vergleichende analyse der gegen rinderproinsulin und rinderinsulin gebildeten antikörper. FEBS Letters. 8(3). 157–160. 1 indexed citations
20.
Schmidt, Delf, et al.. (1968). Proinsulin vom Rind. Iscolierung, Eigenschaften und seine Aktivierung durch Trypsin. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 349(2). 1157–1168. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026